Denmark

Paediatric oncologist involved in early drug development:

• Dr. Karsten NYSOM, Rigshospitalet Copenhagen

Medical oncologist involved in early drug development:

• Dr. Kristoffer STAAL ROHRBERG, Rigshospitalet Copenhagen:

Contact:

Carole LECINSE

ITCC Project Manager/Accelerate FAIR Group coordination

carole.lecinse@gustaveroussy.fr

What does this theme represent for your country?

Pediatric Oncologist:

1½ year ago, our national health authority decided that all cases of cancer in persons younger than 18 years should be treated in paediatrics (paediatric haem-onc), so we have no significant issue of adolescents being treated in adult oncology or haematology, but not being eligible for the trials there. We are keen to open trials earlier for adolescents according to the FAIR principles, and our authorities support this, as well as the sponsors we work with.

Medical oncologist:

Kristoffer Rohrberg (chair of adult oncology phase 1 unit) actively pushes on the industry to include adolescents in early phase oncology trials whenever possible, and who reaches out to Karsten Nysom whenever he hears about a trial where including patients younger than 18 years is an option.